(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methyl-4,6-dihydro-1H-pyrrolo[3,4-d]imidazol-5-yl)oxan-3-amine
C17H20F2N4O — CID 118613829
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methyl-4,6-dihydro-1H-pyrrolo[3,4-d]imidazol-5-yl)oxan-3-amine
(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methyl-4,6-dihydro-1H-pyrrolo[3,4-d]imidazol-5-yl)oxan-3-amine (PubChem CID 118613829) has the molecular formula C17H20F2N4O and a molecular weight of 334.37 g/mol. Its IUPAC name is (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methyl-4,6-dihydro-1H-pyrrolo[3,4-d]imidazol-5-yl)oxan-3-amine.
Molecular Properties
| Compound Name | (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methyl-4,6-dihydro-1H-pyrrolo[3,4-d]imidazol-5-yl)oxan-3-amine |
|---|---|
| PubChem CID | 118613829 |
| Molecular Formula | C17H20F2N4O |
| Molecular Weight | 334.37 g/mol |
| Exact Mass | 334.16 |
| IUPAC Name | (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methyl-4,6-dihydro-1H-pyrrolo[3,4-d]imidazol-5-yl)oxan-3-amine |
| SMILES | Cc1nc2c([nH]1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2 |
| InChI | InChI=1S/C17H20F2N4O/c1-9-21-15-6-23(7-16(15)22-9)11-5-14(20)17(24-8-11)12-4-10(18)2-3-13(12)19/h2-4,11,14,17H,5-8,20H2,1H3,(H,21,22)/t11-,14+,17-/m1/s1 |
| InChIKey | LKXPUPVLYKOKGN-HYSWKAIVSA-N |
| XLogP | 2.17 |
| TPSA | 67.17 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 334.37 |
| LogP ≤ 5 | 2.17 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118613829 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.